The NMI is a member of the Innovation Alliance Baden-Württemberg. It is involved in application-oriented research at the interface between the life sciences and material science. An interdisciplinary team of scientists is developing new technologies for companies and public research sponsors in the areas of pharma and biotechnology, biomedical technology, and surface and materials technology.

Our commitment, professionalism and flexibility are visible in all areas of our work. We manage projects from start to finish – from the planning stage, through to evaluation if required. Our portfolio also includes subprojects and individual services such as consulting, technology assessment, applying for funding, and conceptual planning and coordination of projects. We also offer accredited testing services.

Do get in touch – we'll find a solution!

Foundation and Board of Trustees

The NMI is a non-profit foundation with the Board of Trustees functioning as a volunteer advisory committee. The purpose of the foundation is to present the results of scientific research to the business community with the intention of turning pure research into practical, economically-viable business projects.

Executive Committee of the Foundation

  • Prof. Dr. Katja Schenke-Layland, Chairwoman of the Foundation and Managing Director of the NMI
  • Dr. Thomas Joos, Vice Chairman, NMI
  • Prof. Dr. Matthias Schwab, First Vice Chairman, Dr. Margartete Fischer Bosch Institut für Klinische Pharmakologie
  • Gabriele Sonntag, Second Vice Chairwoman, University Hospital Tübingen

Board of Trustees

  • MinDir G. Leßnerkraus, Chairman of the Board of Trustees, Ministry of Economic Affairs, Baden-Württemberg
  • Prof. Dr. Eberhard Zrenner, Vice Chairman of the Board of Trustees, University of Tübingen
  • Dr. Wolfgang Epp, Vice Chairman of the Board of Trustees, IHK Reutlingen
  • Prof. Dr. Michael Auer, Steinbeis-Stiftung für Wirtschaftsförderung (StW)
  • Dr. Georg Bischopink, Robert Bosch GmbH, Stuttgart
  • Ms. Barbara Bosch, Mayor of Reutlingen
    Represented by Alexander Kreher
  • Prof. Dr. Petra Kluger, University of Reutlingen
  • Dr. Adrian Carter, Boehringer Ingelheim GmbH, Ingelheim
  • Prof. Dr. Bernd Engler, President of the University of Tübingen
    Represented by Prof. Dr. Peter Grathwohl, Vice Cancellor
  • Dr. Ulrich Gottwald, Bayer AG, Berlin
  • Prof. Dr. Peter Gumbsch, Fraunhofer-Institute IWM, Freiburg
  • Dr. Caroline Liepert, Ministerium für Wissenschaft, Forschung und Kunst
  • Prof. Dr. Bernd Pichler, Universität Tübingen
  • Dr. Denis Reibel, Freudenberg New Technologies SE & Co. KG
  • Prof. Dr. Thilo Stehle, Universität Tübingen
  • Dr.-Ing. habil Katrin Sternberg, Aesculap AG
  • Dr. Michael Albiez, Carl Zeiss AG, Oberkochen